this was the text report on EuroCann from the middle of 2020 from A.C. Merchants
1PG - we have all the infrastructure built and the business is a fully licensed pharmaceutical manufacturer with import and distribution licences in Germany which will be the biggest medical cannabis market in the world. We have done 4 test crops with the 5th and 1st commercial crop going in next month. This crop pending the German regulator audit will be EU GMP (delayed due to COVID) which means we will be selling by year end into Germany. COVID has meant delays as we were supposed to have had the crop in Feb and have been selling it by now so we are about 6 months behind schedule. HAPA Pharm is the brand and there’s a bit of info floating around on it at the moment. We will release a full shareholder update once the audit has been completed and first crop sold but it’s pretty impressive and will really wake up the sector I think. Once this is done we will look at liquidity alternatives and see where we go to get the most $$ for our shares.Regards,Andrew
Add to My Watchlist
What is My Watchlist?